Antiviral Activity of Fnc,2′-Deoxy-2′-β-Fluoro-4′-Azidocytidine,against Human and Duck HBV Replication

Srivastav N.C. , Shakya N. , Mak M. , Agrawal B. , Tyrrell D.L. , Kumar R. Antiviral activity of various 1-(2′-deoxy-beta-d-lyxofuranosyl), 1-(2′-fluoro-beta-d-xylofuranosyl), 1-(3′-fluoro-beta-d-arabinofuranosyl), and 2′-fluoro-2′,3′-didehydro-2′,3′-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication. J Med Chem 2010; 53: 7156–7166.

Fan J.M. , Zhang Q. , Xu J. Inhibition on hepatitis B virus in vitro of recombinant MAP30 from bitter melon. Mol Biol Rep 2009; 36: 381–388.

Torbenson M. , Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479–486.

Wu J.M. , Lin J.S. , Xie N. , Liang K.H. Inhibition of hepatitis B virus by a novel l-nucleoside, beta-l-D4A and related analogues. World J Gastroenterol 2003; 9: 1840–1843.

Delaney W.E. , Miller T.G. , Isom H.C. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2′,3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother 1999; 43: 2017–2026.

Guo Q. , Zhao L. , You Q. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res 2007; 74: 16–24.

Wang Q. , Liu X. , Zhang Y. FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells. Biochem Pharmacol 2011; 81: 848–855.

Ohrui H. , Kohgo S. , Hayakawa H. 2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favourable toxic profiles and stability in plasma. Nucleic Acids Symp Ser (Oxf) 2006; 50: 1–2.

Klumpp K. , Kalayanov G. , Ma H. 2′-Deoxy-4′-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2′-alpha-hydroxyl groups. J Biol Chem 2008; 283: 2167–2175.

Gao L.L. , Wang X.Y. , Lin J.S. , Zhang Y.H. , Li Y. Efficacies of beta-l-D4A against hepatitis B virus in 2.2.15 cells. World J Gastroenterol 2008; 14: 1263–1267.

Jahn B. , Martin E. , Stueben A. , Bhakdi S. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol 1995; 33: 661–667.

Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.

Ferrari M. , Fornasiero M.C. , Isetta A.M. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods 1990; 131: 165–172.

Pang R. , Tao J. , Zhang S. In vitro anti-hepatitis B virus effect of Hypericum perforatum L. J Huazhong Univ Sci Technolog Med Sci 2010; 30: 98–102.

Liu Y-K , Zheng L. , Chang J-B . Development and application of real-time PCR assay for detection of duck hepatitis B virus. Journal of Yangzhou University (Agricultural and Life Science Edition) 2010; 31: 7–12.

Li J. , Huang H. , Feng M. , Zhou W. , Shi X. , Zhou P. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L. Antiviral Res 2008; 79: 114–120.

Günther S. , Li B.C. , Miska S. , Krüger D.H. , Meisel H. , Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immonusuppressed patients. J Virol 1995; 69: 5437–5444.

Marion P.L. , Salazar F.H. , Winters M.A. , Colonno R.J. Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication. Antimicrob Agents Chemother 2002; 46: 82–88.

Xie H.Y. , Xia W.L. , Zhang C.C. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment. Acta Pharmacol Sin 2007; 28: 975–984.

Liu T. , Zhao J. , Li H. , Ma L. Evaluation on anti-hepatitis viral activity of Vitis vinifer L. Molecules 2010; 15: 7415–7422.

Lai C.L. , Yuen M.F. Profound suppression of hepatitis B virus replication with lamivudine. J Med Virol 2000; 61: 367–373.

He Y.W. , Guo C.X. , Pan Y.F. , Peng C. , Weng Z.H. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro. World J Gastroenterol 2008; 14: 1592–1597.

Levine S. , Hernandez D. , Yamanaka G. Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro. Antimicrob Agents Chemother 2002; 46: 2525–2532.

Lin M. , Yang L.Y. , Li W.Y. , Peng Y.P. , Zheng J.K. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. J Int Med Res 2009; 37: 1411–1419.

Han Y.Q. , Huang Z.M. , Yang X.B. , Liu H.Z. , Wu G.X. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. J Ethnopharmacol 2008; 118: 148–153.

Zoulim F. Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies. Antiviral Res 1999; 44: 1–30.

Schiller J.T. , Lowy D.R. Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol 2010; 64: 23–41.

Li C.Q. , Zhu Y.T. , Zhang F.X. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J Gastroenterol 2005; 11: 426–428.

Chu C.K. , Boudinot F.D. , Peek S.F. Preclinical investigation of l-FMAU as an anti-hepatitis B virus agent. Antivir Ther 1998; 3: 113–121.

Chen Y.X. , Huang A.L. , Qi Z.Y. , Shan Y.L. , Sun H. Assessment of a method for detecting serum HBV DNA with HBV DNA probe labelled directly by alkaline phosphatise. Hepatobiliary Pancreat Dis Int 2003; 2: 553–556.

Dong B. , Shao X.W. , Tao P.Z. Inhibition of duck hepatitis B virus DNA replication by antisense phosphorothioate oligodeoxynucleotides in vitro and in vivo. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003; 17: 25–27.